Discovery of a new role of human resistin in hepatocyte low-density lipoprotein receptor suppression mediated in part by proprotein convertase subtilisin/kexin type 9

JACC - Journal of the American College of Cardiology, 05/11/2012

These results reveal for the first time that resistin is a highly attractive therapeutic target in ameliorating elevated serum low–density lipoprotein and, thereby, atherosclerotic cardiovascular diseases in obese humans.

Print Article Summary Cat 2 CME Report